Do Off-Label Drug Practices Argue Against FDA Efficacy Requirements? Testing an Argument by Structured Conversations with Experts
Download full text from publisher
References listed on IDEAS
- Keith, Alison, 1995. "Regulating Information about Aspirin and the Prevention of Heart Attack," American Economic Review, American Economic Association, vol. 85(2), pages 96-99, May.
More about this item
KeywordsFood and Drug Administration; drug approval; efficacy requirements; off-label uses; on-label uses; certification; liberalization;
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
NEP fieldsThis paper has been announced in the following NEP Reports:
- NEP-ALL-2004-01-18 (All new papers)
- NEP-COM-2004-01-18 (Industrial Competition)
- NEP-EDU-2004-01-18 (Education)
- NEP-HEA-2004-01-18 (Health Economics)
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hhs:ratioi:0028. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Martin Korpi). General contact details of provider: http://edirc.repec.org/data/ratiose.html .